Medipolis GMP, a Finnish company based in Oulu, and Bioton SA, a Polish pharmaceutical company, have signed a licensing agreement on the manufacturing technology research project of an insulin analog used in treating diabetes. The licensing agreement is the final... » read more
In what promises to be the biggest bioscience firm deal in state history, Selexys Pharmaceuticals Corp. has struck an agreement that could lead to the company's acquisition for up to $665 million.
"This is the largest, by far, pharmaceutical deal ever... » read more
Sanofi SA and the Global Alliance for TB Drug Development, or TB Alliance, a not-for-profit organization developing regimens for TB, have announced a new research collaboration agreement to accelerate the discovery and development of novel compounds against tuberculosis, or TB.
Under... » read more
Phase III study results show that investigational RLX030 (serelaxin) reduced all-cause mortality in patients with acute heart failure (AHF). The six-month RELAX-AHF study shows that RLX030 reduces the number of deaths in patients with this disease, which has a higher... » read more
Roche Holding Ltd, which announced last summer it will leave its longtime research and development site in Nutley, NJ, has opted to leave New Jersey for New York City.
The global biotech and pharmaceutical company has signed an 11-year lease with... » read more
